Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria
Authors:
Open Access
- 14 August 2025
- journal article
- Published by Springer Nature in Pituitary
- Vol. 28 (5) , 91
Abstract
Background: The Pituitary Society established criteria to develop Pituitary Tumor Centers of Excellence (PTCOE) for optimization of patient care. These criteria were later transformed into quantitative standards based on real-life data from accredited pituitary centers worldwide. The aim of this study was to evaluate the pituitary tumor care capacity at our institute and compare it with the PTCOE criteria. Method: We retrospectively reviewed the data of patients who underwent sellar, suprasellar, or parasellar surgery during 2021–2023 at Taipei Veterans General Hospital. Adults older than 18 years who were diagnosed with pituitary tumors were included. We collected data regarding baseline patient and tumor characteristics, the surgical method, complications, and activity volumes across involved departments. The relevant data were compared with those of the PTCOE standards. Results: In total, 182 patients with pituitary tumors underwent surgery via the endoscopic endonasal approach during 2021–2023. Their median age was 51 (range, 20–91) years. Among them, 90.7% had macroadenomas. Functional remission rates were 55.6% for acromegaly, 69.2% for prolactinoma, and 93.3% for Cushing’s disease. Our institute met the acceptable PTCOE criteria for the number of pituitary interventions, postoperative readmissions for complications, dynamic endocrine tests, neuroradiologists, and neuro-oncologists. Further, we met the preferred PTCOE criteria for mortality rate and the numbers of dedicated surgeons, endocrinologists, trained nurses, neuropathologists, and neuro-ophthalmologists. Conclusion: Most indicators in our study met the acceptable standards for a PTCOE. During the study period, the multidisciplinary team at our institute collaborated closely to provide comprehensive care for patients with pituitary adenomas.Keywords
All Related Versions
Funding Information
- National Yang Ming Chiao Tung University
This publication has 22 references indexed in Scilit:
- Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical managementPituitary, 2019
- Clinical Outcomes After Endoscopic Endonasal Resection of Giant Pituitary AdenomasWorld Neurosurgery, 2018
- Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complicationsActa Neurochirurgica, 2017
- Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society StatementPituitary, 2017
- Outcome of Endoscopic Transsphenoidal Surgery for AcromegalyWorld Neurosurgery, 2017
- Readmission and Other Adverse Events after Transsphenoidal Surgery: Prevalence, Timing, and Predictive FactorsJournal of the American College of Surgeons, 2017
- Current best practice in the management of patients after pituitary surgeryTherapeutic Advances in Endocrinology and Metabolism, 2017
- Outcome Of Implementation Of A Multidisciplinary Team Approach To The Care Of Patients After Transsphenoidal SurgeryEndocrine Practice, 2016
- Successful Mortality Reduction and Control of Comorbidities in Patients With Acromegaly Followed at a Highly Specialized Multidisciplinary ClinicThe Journal of Clinical Endocrinology & Metabolism, 2014
- Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysisPituitary, 2011